Refusal Trend Tied To Scary Newborn Bleeds

newborns in hospital bassinets — Photo: sukanya sitthikongsak / Shutterstock

One simple shot after birth now marks a real line between a scare and a tragedy.

Story Snapshot

A national study of 5.2 million infants linked skipping vitamin K to more bleeding.
Bleeding within six months rose about 47% when babies did not get the shot.
Intracranial bleeding risk more than doubled without vitamin K, a grave outcome.
Refusals climbed from 3.1% in 2017 to 6.8% in 2025, more than doubling.

What the new studies actually measured

Researchers reviewed electronic health records for more than 5.2 million U.S. infants born from 2017 to 2025. They compared babies who received intramuscular vitamin K at birth with those who did not. Any bleeding within six months occurred in 288 per 10,000 births among nonrecipients, versus 186 per 10,000 among recipients, a clear gap across a very large sample. The companion report translated the difference this way: about a 47% higher risk of bleeding in infants who skipped the shot.

Severe outcomes told the sharper story. Intracranial bleeding, which can cause seizures, disability, or death, occurred at 33.0 per 10,000 births among nonrecipients and 13.2 per 10,000 among recipients. After adjustment, the relative risk was 2.43, with a tight confidence band, which means the finding was precise in this dataset. A second national analysis of more than 11 million infants tracked diagnoses over time and found that vitamin K deficiency and related bleeding rose as supplementation declined.

A quiet trend is becoming a problem

Refusal of the newborn vitamin K shot rose from 3.1% in 2017 to 6.8% in 2025. That means the share more than doubled in less than a decade, while the overall shot rate slipped from about 98% to 95%. Children’s Hospital of Philadelphia highlighted this change as worrisome because even small drops in coverage can expose more infants to rare but severe bleeds. The science team framed the message plainly: lower acceptance, more bleeding diagnoses, including the brain.

These results match earlier work that pointed the same way. A prior study reported higher odds of bleeding, and of intracranial bleeding in particular, among infants who did not get the shot. The pattern and direction agree across different datasets and methods, even as each study uses its own record systems and models. The new studies add scale and stronger precision, which helps separate a true signal from noise in rare events.

Why newborns need vitamin K

Newborns start life with very low vitamin K. That vitamin is needed to make clotting factors that stop bleeding. Breast milk has little vitamin K, and the baby’s gut does not yet make enough of it. A single intramuscular dose at birth fills that gap for weeks, covering the high-risk window when silent internal bleeding can strike. The American Academy of Pediatrics has recommended this one-time dose since 1961, and hospitals have used it as routine care for decades.

Parents sometimes ask for oral drops instead. The data in these studies focus on the standard intramuscular dose. Oral regimens can work if given on strict schedules, but they are easier to miss and are not the U.S. standard. The core point from the new evidence is narrow and strong: babies who skip the intramuscular shot bled more, and the difference was largest for bleeds that matter most, including the brain.

How to read the risk like a grown-up

The absolute risk of any bleed is still low. Most babies will not bleed either way. But public health is about small probabilities times many lives. When refusal doubles or triples the risk of a brain bleed, even at low base rates, those extra cases are not statistics to the families who face them. The studies used observational data, which cannot prove causation for every case, but the direction, size, and consistency align with physiology and long experience.

Common sense fits here. A one-time, low-cost shot that reduces a rare but devastating risk is the kind of prevention that built modern pediatrics. It respects parental love by protecting the child’s future brain and life. The trend line is going the wrong way. Hospitals and doctors should give parents straight talk in plain words, show the numbers once, then focus on the outcome that matters: fewer tiny funerals, fewer long nights in neurosurgery, more babies home and fine.